chr1-110061531-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS1
The NM_006492.3(ALX3):c.627G>A(p.Arg209Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000333 in 1,614,202 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.0019   (  0   hom.,  cov: 33) 
 Exomes 𝑓:  0.00017   (  0   hom.  ) 
Consequence
 ALX3
NM_006492.3 synonymous
NM_006492.3 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  1.37  
Publications
0 publications found 
Genes affected
 ALX3  (HGNC:449):  (ALX homeobox 3) This gene encodes a nuclear protein with a homeobox DNA-binding domain that functions as a transcriptional regulator involved in cell-type differentiation and development. Preferential methylation of this gene's promoter is associated with advanced-stage neuroblastoma tumors. [provided by RefSeq, Jul 2008] 
 STRIP1  (HGNC:25916):  (striatin interacting protein 1) This gene encodes a member of the striatin-interacting phosphatase and kinase complex, which is involved in localization of the Golgi body. The encoded protein participates in cytosketelal organization. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2012] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36). 
BP6
Variant 1-110061531-C-T is Benign according to our data. Variant chr1-110061531-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 259986.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BP7
Synonymous conserved (PhyloP=1.37 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00188 (287/152342) while in subpopulation AFR AF = 0.00659 (274/41572). AF 95% confidence interval is 0.00595. There are 0 homozygotes in GnomAd4. There are 143 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| ALX3 | ENST00000647563.2 | c.627G>A | p.Arg209Arg | synonymous_variant | Exon 3 of 4 | NM_006492.3 | ENSP00000497310.1 | |||
| ALX3 | ENST00000649954.1 | c.198G>A | p.Arg66Arg | synonymous_variant | Exon 2 of 3 | ENSP00000497035.1 | ||||
| ENSG00000258634 | ENST00000554749.1 | n.3192C>T | non_coding_transcript_exon_variant | Exon 1 of 1 | 6 | |||||
| STRIP1 | ENST00000473429.5 | n.4213+6729C>T | intron_variant | Intron 12 of 13 | 2 | 
Frequencies
GnomAD3 genomes  0.00185  AC: 282AN: 152224Hom.:  0  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
282
AN: 
152224
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.000402  AC: 101AN: 251430 AF XY:  0.000258   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
101
AN: 
251430
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.000172  AC: 251AN: 1461860Hom.:  0  Cov.: 31 AF XY:  0.000140  AC XY: 102AN XY: 727238 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
251
AN: 
1461860
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
102
AN XY: 
727238
show subpopulations 
African (AFR) 
 AF: 
AC: 
189
AN: 
33480
American (AMR) 
 AF: 
AC: 
10
AN: 
44722
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26134
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39700
South Asian (SAS) 
 AF: 
AC: 
3
AN: 
86256
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
53404
Middle Eastern (MID) 
 AF: 
AC: 
2
AN: 
5768
European-Non Finnish (NFE) 
 AF: 
AC: 
5
AN: 
1112000
Other (OTH) 
 AF: 
AC: 
42
AN: 
60396
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.478 
Heterozygous variant carriers
 0 
 15 
 30 
 45 
 60 
 75 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 10 
 20 
 30 
 40 
 50 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.00188  AC: 287AN: 152342Hom.:  0  Cov.: 33 AF XY:  0.00192  AC XY: 143AN XY: 74478 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
287
AN: 
152342
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
143
AN XY: 
74478
show subpopulations 
African (AFR) 
 AF: 
AC: 
274
AN: 
41572
American (AMR) 
 AF: 
AC: 
8
AN: 
15310
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5184
South Asian (SAS) 
 AF: 
AC: 
1
AN: 
4830
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10626
Middle Eastern (MID) 
 AF: 
AC: 
1
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
68028
Other (OTH) 
 AF: 
AC: 
3
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.498 
Heterozygous variant carriers
 0 
 15 
 30 
 46 
 61 
 76 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 4 
 8 
 12 
 16 
 20 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
5
AN: 
3478
ClinVar
Significance: Benign/Likely benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not specified    Benign:1 
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided    Benign:1 
Aug 29, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.